本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Syndax Pharmaceuticals, Inc.

13.79
-0.3600-2.54%
成交量:54.50万
成交额:756.91万
市值:11.87亿
市盈率:-3.70
高:14.20
开:14.16
低:13.68
收:14.15
数据加载中...
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/26

重要事件披露

Form 8-K - Current report
2023/05/18

重要事件披露

Form 8-K - Current report
2023/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/30

重要事件披露

8-K - Current report
2023/02/28

重要事件披露

8-K - Current report
2023/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

重要事件披露

8-K - Current report
2023/01/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals